After 25 years in South San Francisco, biopharmaceutical company and cancer drug developer Exelixis (NYSE: EXEL) has signed a 10-year lease with Ascentris to relocate its corporate headquarters to three buildings within The Waterfront in Alameda, CA.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In